During the last session, Bionano Genomics Inc (NASDAQ:BNGO)’s traded shares were 3.26 million, with the beta value of the company hitting 2.30. At the end
During the last session, Bionano Genomics Inc (NASDAQ:BNGO)’s traded shares were 3.93 million, with the beta value of the company hitting 2.31. At the end
In the last trading session, 2.8 million shares of the Bionano Genomics Inc (NASDAQ:BNGO) were traded, and its beta was 2.31. Most recently the company’s
In the last trading session, 2.99 million Bionano Genomics Inc (NASDAQ:BNGO) shares changed hands as the company’s beta touched 2.32. With the company’s per share
In the last trading session, 4.95 million Bionano Genomics Inc (NASDAQ:BNGO) shares changed hands as the company’s beta touched 2.34. With the company’s per share
In last trading session, Bionano Genomics Inc (NASDAQ:BNGO) saw 3.32 million shares changing hands with its beta currently measuring 2.36. Company’s recent per share price
Bionano Genomics Inc (NASDAQ:BNGO) has a beta value of 2.37 and has seen 2.12 million shares traded in the last trading session. The company, currently
During the last session, Bionano Genomics Inc (NASDAQ:BNGO)’s traded shares were 5.49 million, with the beta value of the company hitting 2.33. At the end
In the last trading session, 1.42 million shares of the Bionano Genomics Inc (NASDAQ:BNGO) were traded, and its beta was 2.33. Most recently the company’s
In the last trading session, 3.23 million shares of the Bionano Genomics Inc (NASDAQ:BNGO) were traded, and its beta was 2.33. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
